CompletedNot Applicable

Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality

Denmark11,196 participantsStarted 2014-01-01

Plain-language summary

This study evaluates the use and effects of supplementary oxygen in surgical and medical wards on patients admitted to a hospital in the capital region of Denmark. The population will be divided in to three groups according to their oxygenation status. The main outcome will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive protein, S-Creatinine, Troponin.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admission date between 1st of January 2014 to 29th of December 2014 on a hospital in the capital region of Denmark * Age ≥18 * Unique (first) admission in database for either: * Hip fracture requiring surgery * Chronic obstructive pulmonary disease in exacerbation * Acute mycardial infarction * Open abdominal surgery Exclusion Criteria: * No data on saturation within 48 hours after * Admission (Medical patients) * Discharge from the post anaesthesia care unit (Surgical patients) * No data on primary outcome (30-day mortality)

What they're measuring

30- day mortality

Timeframe: 30 days

Trial details

NCT IDNCT03625700

SponsorHannibal Troensegaard

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-08

View on ClinicalTrials.gov More Oxygen Toxicity trials